Industry News
-
AAV Gene Therapy Advances Offer Hope for Ultra-Rare PUS3 Syndrome
Apr 13 2026 -
University of Colorado Advances First-In-Human CD64 CAR-T Therapy for AML Following FDA IND Clearance
Apr 12 2026 -
FDA Points to Regulatory Innovation Supporting Cell and Gene Therapy Development
Apr 09 2026 -
Dyno Therapeutics Licenses AI-Designed AAV Capsid to Astellas for Muscle Gene Therapy
Apr 08 2026 -
Life Biosciences Raises $80M to Advance AAV Gene Therapy for Partial Epigenetic Reprogramming in Vision Loss
Apr 08 2026 -
Genflow Reports Positive Durability Data for AAV-Based SIRT6 Gene Therapy in Aging Dog Trial
Apr 08 2026 -
Respiratory Gene Therapy Advances Toward Clinical Reality for Cystic Fibrosis and Rare Lung Diseases
Apr 06 2026 -
Opus Genetics Secures Up to $155M Non-Dilutive Financing to Accelerate Gene Therapy Pipeline for Inherited Retinal Diseases
Apr 06 2026 -
FDA Accepts BLA for Ultragenyx AAV9 Gene Therapy UX111 for Sanfilippo Syndrome Type A
Apr 02 2026